Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

No Evidence of SARS-CoV-2 Circulation in Rome (Italy) during the Pre-Pandemic Period: Results of a Retrospective Surveillance.

Tytuł:
No Evidence of SARS-CoV-2 Circulation in Rome (Italy) during the Pre-Pandemic Period: Results of a Retrospective Surveillance.
Autorzy:
Capalbo C; Sant'Andrea Hospital, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.; Department of Molecular Medicine, University La Sapienza, viale Regina Elena 291, 00161 Rome, Italy.
Bertamino E; Sant'Andrea Hospital, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.; Department of Public Health and Infectious Diseases, University La Sapienza, Piazzale Aldo Moro 5, 00185 Rome, Italy.
Zerbetto A; Sant'Andrea Hospital, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.; Department of Public Health and Infectious Diseases, University La Sapienza, Piazzale Aldo Moro 5, 00185 Rome, Italy.
Santino I; Sant'Andrea Hospital, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.; Department of Clinical and Molecular Medicine, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.
Petrucca A; Sant'Andrea Hospital, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.
Mancini R; Sant'Andrea Hospital, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.; Department of Clinical and Molecular Medicine, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.
Bonfini R; Sant'Andrea Hospital, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.
Alfonsi V; Sant'Andrea Hospital, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.
Ferracuti S; Sant'Andrea Hospital, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.; Department of Human Neurosciences, University La Sapienza, Piazzale Aldo Moro 5, 00185 Rome, Italy.
Marchetti P; Sant'Andrea Hospital, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.; Department of Clinical and Molecular Medicine, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.
Simmaco M; Sant'Andrea Hospital, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.; Department of Neurosciences, Mental Health, and Sensory Organs, 'Sapienza' University of Rome, via di Grottarossa 1035-1039, 00189 Rome, Italy.
Orsi GB; Sant'Andrea Hospital, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.; Department of Public Health and Infectious Diseases, University La Sapienza, Piazzale Aldo Moro 5, 00185 Rome, Italy.
Napoli C; Sant'Andrea Hospital, University La Sapienza, via di Grottarossa 1035-1039, 00189 Rome, Italy.; Department of Medical Surgical Sciences and Translational Medicine, University La Sapienza, via di Grottarossa 1035/1039, 00189 Rome, Italy.
Źródło:
International journal of environmental research and public health [Int J Environ Res Public Health] 2020 Nov 16; Vol. 17 (22). Date of Electronic Publication: 2020 Nov 16.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basel : MDPI, c2004-
MeSH Terms:
Coronavirus Infections/*epidemiology
Pneumonia, Viral/*epidemiology
Betacoronavirus ; COVID-19 ; Epidemiological Monitoring ; Humans ; Pandemics ; Retrospective Studies ; Rome/epidemiology ; SARS-CoV-2 ; Severe Acute Respiratory Syndrome/diagnosis ; Severe Acute Respiratory Syndrome/etiology
References:
Lancet. 2020 Feb 15;395(10223):470-473. (PMID: 31986257)
Disaster Med Public Health Prep. 2020 Jun;14(3):372-376. (PMID: 32207676)
Vaccines (Basel). 2020 Jul 30;8(3):. (PMID: 32751584)
Cell Death Dis. 2020 Sep 24;11(9):799. (PMID: 32973152)
Sci Total Environ. 2020 Sep 20;736:139652. (PMID: 32464333)
Int J Environ Res Public Health. 2020 May 27;17(11):. (PMID: 32471066)
Expert Rev Vaccines. 2019 Jun;18(6):671-679. (PMID: 31159616)
Sci Total Environ. 2021 Jan 1;750:141711. (PMID: 32835962)
Int J Environ Res Public Health. 2015 Dec 08;12(12):15550-8. (PMID: 26670237)
Radiology. 2020 Aug;296(2):E97-E104. (PMID: 32339082)
Int J Antimicrob Agents. 2020 Jun;55(6):106006. (PMID: 32371096)
Aliment Pharmacol Ther. 2020 May;51(9):843-851. (PMID: 32222988)
Int J Environ Res Public Health. 2020 Jun 19;17(12):. (PMID: 32575505)
Contributed Indexing:
Keywords: COVID-19; SARS-CoV-2; coronavirus; epidemiological and etiological surveillance; influenza-like syndrome; pneumonia
Entry Date(s):
Date Created: 20201119 Date Completed: 20201123 Latest Revision: 20201218
Update Code:
20240105
PubMed Central ID:
PMC7696939
DOI:
10.3390/ijerph17228461
PMID:
33207548
Czasopismo naukowe
In March 2020, the World Health Organization (WHO) declared that the COVID-19 outbreak recorded over the previous months could be characterized as a pandemic. The first known Italian SARS-CoV-2 positive case was reported on 21 February. In some countries, cases of suspected "COVID-19-like pneumonia" had been reported earlier than those officially accepted by health authorities. This has led many investigators to check preserved biological or environmental samples to see whether the virus was detectable on dates prior to those officially stated. With regard to Italy, the results of a microbiological screening in sewage samples collected between the end of February and the beginning of April 2020 from wastewaters in Milan (Northern Italy) and Rome (Central Italy) showed presence of SARS-CoV-2. In the present study, we evaluated, by means of a standardized diagnostic method, the SARS-CoV-2 infection prevalence amongst patients affected by severe acute respiratory syndrome (SARI) in an academic hospital located in Central Italy during the period of 1 November 2019-1 March 2020. Overall, the number of emergency room (ER) visits during the investigated period was 13,843. Of these, 1208 had an influenza-like syndrome, but only 166 matched the definition of SARI as stated in the study protocol. A total of 52 SARI cases were laboratory confirmed as influenza: 26 as a type B virus, 25 as a type A, and 1 as both viruses. Although about 17% of the total sample had laboratory or radiological data compatible with COVID-19, all the nasopharyngeal swabs stored underwent SARS-CoV-2 RT-PCR and tested negative. Based on our result, it is confirmed that the COVID-19 pandemic spread did not start prior to the "official" onset in central Italy. Routine monitoring of SARI causative agents at the local level is critical for reporting epidemiologic and etiologic trends that may differ from one country to another and also among different influenza seasons. This has a practical impact on prevention and control strategies.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies